Towards Scalable Biomarker Discovery in Posttraumatic Stress Disorder: Triangulating Genomic and Phenotypic Evidence from a Health System Biobank
Authors:
- Younga Heather LeeYLYounga Heather Lee
- Yingzhe ZhangYZYingzhe Zhang
- Ana Lucia Espinosa DiceADAna Lucia Espinosa Dice
- Josephine H. LiJLJosephine H. Li
- Justin D. TubbsJTJustin D. Tubbs
- Yen-Chen Anne FengYFYen-Chen Anne Feng
- Tian GeTGTian Ge
- Adam X. MaihoferAMAdam X. Maihofer
- Caroline M. NievergeltCNCaroline M. Nievergelt
- Jordan W. SmollerJSJordan W. Smoller
- Karestan C. KoenenKKKarestan C. Koenen
- Andrea L. RobertsARAndrea L. Roberts
Preprint
Abstract
Importance: Biomarkers can potentially improve the diagnosis, monitoring, and treatment of posttraumatic stress disorder (PTSD). However, PTSD biomarkers that are scalable and easily integrated into real-world clinical settings have not been identified. Objective: To triangulate phenotypic and genomic evidence from a health system biobank with a goal of identifying scalable and clinically relevant biomarkers for PTSD. Design, setting, and participants: The analysis was conducted between June to November 2024 using genomic samples and laboratory test results recorded in the Mass General Brigham (MGB) Health System. The analysis included 23,743 European ancestry participants from the nested MGB Biobank study. Exposures: The first exposure was polygenic risk score (PRS) for PTSD, calculated using the largest available European ancestry genome-wide association study (GWAS), employing a Bayesian polygenic scoring method. The second exposure was a clinical diagnosis of PTSD, determined by the presence of two or more qualifying PTSD phecodes in the longitudinal electronic health records (EHR). Main outcomes and measures: The primary outcomes were the inverse normal quantile transformed, median lab values of 241 laboratory traits with non-zero h 2 SNP estimates. Results: Sixteen unique laboratory traits across the cardiometabolic, hematologic, hepatic, and immune systems were implicated in both genomic and phenotypic lab-wide association scans (LabWAS). Two-sample Mendelian randomization analyses provided evidence of potential unidirectional causal effects of PTSD liability on five laboratory traits. Conclusion and relevance: These findings demonstrate the potential of a triangulation approach to uncover scalable and clinically relevant biomarkers for PTSD. Key points: Question: Is genetic liability or diagnosis of PTSD associated with clinical laboratory measures? Findings: Among European ancestry participants in the MGB Biobank, we identified 16 unique laboratory traits in cardiometabolic, hematologic, hepatic, and immune systems that were both genetically and phenotypically associated with PTSD, with five markers demonstrating potential unidirectional causal effects of PTSD liability. Meaning: Our findings reveal associations between PTSD and laboratory markers across multiple physiological systems, with evidence suggesting possible unidirectional causal effects of PTSD liability on cardiometabolic, hematologic, and hepatic markers.Keywords
This publication has 67 references indexed in Scilit:
- Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory OutcomesJAMA Psychiatry, 2024
- Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell CountJAMA Psychiatry, 2021
- Methylomic profiles reveal sex-specific differences in leukocyte composition associated with post-traumatic stress disorderBrain, Behavior, and Immunity, 2019
- Causes of Excess Mortality in Veterans Treated for Posttraumatic Stress DisorderAmerican Journal of Preventive Medicine, 2019
- Epidemiology, genetic epidemiology and Mendelian randomisation: more need than ever to attend to detailHuman Genetics, 2019
- Understanding the Assumptions Underlying Instrumental Variable Analyses: a Brief Review of Falsification Strategies and Related ToolsCurrent Epidemiology Reports, 2018
- Bias due to participant overlap in two‐sample Mendelian randomizationGenetic Epidemiology, 2016
- Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience ResearchBiological Psychiatry, 2015
- Posttraumatic Stress Disorder and Incidence of Type 2 Diabetes Mellitus in a Sample of WomenJAMA Psychiatry, 2015
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011